Subjects at greater risk of HHF aftertaking sitagliptin were those without severe hypoglycemia, without ACE inhibitorstreatment, with history of heart failure or receiving hemodialysis rather thanperitoneal dialysis. The gene discussed is ACE; the disease is Hypoglycemia.